Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.47 USD 1.36%
Updated: May 20, 2024

Design Therapeutics Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Design Therapeutics Inc
Stock-Based Compensation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Stock-Based Compensation
$13.1m
CAGR 3-Years
208%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Stock-Based Compensation
$782m
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Stock-Based Compensation
$788m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Stock-Based Compensation
$650.7m
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Design Therapeutics Inc's Stock-Based Compensation?
Stock-Based Compensation
13.1m USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Stock-Based Compensation amounts to 13.1m USD.

What is Design Therapeutics Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 3Y
208%

Over the last year, the Stock-Based Compensation growth was 20%. The average annual Stock-Based Compensation growth rates for Design Therapeutics Inc have been 208% over the past three years .